Hyal-AT2101 Hyanalgese-D topical gel formulation of hyaluronic acid and diclofenac data

HYALF (Mississauga, Ontario) announced that Phase III tests show that the agent relieved pain. HYALF declined to disclose the data, but said the results were statistically significant.

The trial used the agent in addition to oral NSAID to relieve uncontrolled pain. Of 120 patients enrolled, the 60 who applied the agent four times daily to the skin over a painful arthritic joint for two weeks assessed the agent as providing a sustained analgesic effect, including overnight action, compared to placebo. ...